S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

EYPT EyePoint Pharmaceuticals Inc

9.05

0.05 (0.56%)

28 Nov 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals Inc News

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Monday 18 November 2024 (1 week ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (3 weeks ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments
Thursday 7 November 2024 (3 weeks ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Monday 4 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 1 November 2024 (4 weeks ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
Friday 1 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 31 October 2024 (4 weeks ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
Wednesday 30 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 29 October 2024 (1 month ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
Tuesday 29 October 2024 (1 month ago) • GlobeNewswire Inc.

More EyePoint Pharmaceuticals Inc News Articles

Fulcrum Utility Services...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions